BRAF Mutation Diversity and Impact on Clinical Outcomes in Non-Small Cell Lung Cancer

被引：0
|
作者：
Lu, K. [1 ]
Shen, J. P. [2 ]
Lopez-Diaz, F. J. [3 ]
Leal, A. [4 ]
Woodward, B. D. [1 ]
Velcheti, V. [4 ]
Riess, J. W. [5 ]
Mansfield, A. S. [6 ]
Salgia, R. [7 ]
Husain, H. [1 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] CEPIMP Genom, Cordoba, Argentina
[4] NYU Langone, New York, NY USA
[5] Univ Calif Davis, Sacramento, CA USA
[6] Mayo Clin, Rochester, MN USA
[7] City Hope Natl Med Ctr, Duarte, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
BRAF; NSCLC; Targeted Therapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.12C.01
引用
收藏
页码：S341 / S341
页数：1
相关论文
共 50 条
  • [1] BRAF Inhibitors in Non-Small Cell Lung Cancer
    Sforza, Vincenzo
    Palumbo, Giuliano
    Cascetta, Priscilla
    Carillio, Guido
    Manzo, Anna
    Montanino, Agnese
    Sandomenico, Claudia
    Costanzo, Raffaele
    Esposito, Giovanna
    Laudato, Francesca
    Damiano, Simona
    Forte, Cira Antonietta
    Frosini, Giulia
    Farese, Stefano
    Piccirillo, Maria Carmela
    Pascarella, Giacomo
    Normanno, Nicola
    Morabito, Alessandro
    CANCERS, 2022, 14 (19)
  • [2] Immunotherapy Benefit in a Patient With Non-Small Cell Lung Cancer and a Rare BRAF Mutation
    Rittberg, Rebekah
    Banerji, Shantanu
    Green, Susan
    Qing, Gefei
    Dawe, David E.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (10)
  • [3] Pathways and targeting avenues of BRAF in non-small cell lung cancer
    Imyanitov, Evgeny N.
    Mitiushkina, Natalia V.
    Kuligina, Ekatherina Sh.
    Tiurin, Vladislav I.
    Venina, Aigul R.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2024, 28 (07) : 613 - 622
  • [4] Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation
    Ambrosini-Spaltro, Andrea
    Rengucci, Claudia
    Capelli, Laura
    Chiadini, Elisa
    Calistri, Daniele
    Bennati, Chiara
    Cravero, Paola
    Limarzi, Francesco
    Nosseir, Sofia
    Panzacchi, Riccardo
    Valli, Mirca
    Ulivi, Paola
    Rossi, Giulio
    CURRENT ONCOLOGY, 2023, 30 (11) : 10019 - 10032
  • [5] The Association Between BRAF Mutation Class and Clinical Features in BRAF-Mutant Chinese Non-Small Cell Lung Cancer Patients
    Lin, Q.
    Zhu, H.
    Li, Y.
    Zhang, H.
    Ding, H.
    Qian, J.
    Han-Zhang, H.
    Lin, J.
    Xiang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S363 - S363
  • [6] Mutation Profile of BRAF in Chinese Non-Small Cell Lung Cancer Patients
    Ai, X.
    Li, Y.
    Chen, R.
    Gu, D.
    Mao, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1149 - S1149
  • [7] Therapeutic strategies for BRAF mutation in non-small cell lung cancer: a review
    Puri, Megha
    Gawri, Kunal
    Dawar, Richa
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [8] BRAF in non-small cell lung cancer: From molecular mechanisms to clinical practice
    Parisi, Claudia
    Planchard, David
    CANCER, 2025, 131
  • [9] Impact of EGFR mutation and ALK rearrangement on the outcomes of non-small cell lung cancer patients with brain metastasis
    Balasubramanian, Suresh K.
    Sharma, Mayur
    Venur, Vyshak A.
    Schmitt, Philipp
    Kotecha, Rupesh
    Chao, Samuel T.
    Suh, John H.
    Angelov, Lilyana
    Mohammadi, Alireza M.
    Vogelbaum, Michael A.
    Barnett, Gene H.
    Jia, Xuefei
    Pennell, Nathan A.
    Ahluwalia, Manmeet S.
    NEURO-ONCOLOGY, 2020, 22 (02) : 267 - 277
  • [10] The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients
    Quan Lin
    Haoran Zhang
    Huaxin Ding
    Jun Qian
    Analyn Lizaso
    Jing Lin
    Han Han-Zhang
    Jianxing Xiang
    Yuping Li
    Hong Zhu
    Journal of Translational Medicine, 17
12345